DE69009989T2 - Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. - Google Patents
Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.Info
- Publication number
- DE69009989T2 DE69009989T2 DE69009989T DE69009989T DE69009989T2 DE 69009989 T2 DE69009989 T2 DE 69009989T2 DE 69009989 T DE69009989 T DE 69009989T DE 69009989 T DE69009989 T DE 69009989T DE 69009989 T2 DE69009989 T2 DE 69009989T2
- Authority
- DE
- Germany
- Prior art keywords
- chlormethiazole
- neurodegeneration
- prophylaxis
- therapy
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8900564A SE8900564D0 (sv) | 1989-02-17 | 1989-02-17 | Novel medicinal use |
| PCT/SE1990/000093 WO1990009174A1 (en) | 1989-02-17 | 1990-02-13 | Use of chlormethiazole in the prevention and/or treatment of neurodegeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69009989D1 DE69009989D1 (de) | 1994-07-21 |
| DE69009989T2 true DE69009989T2 (de) | 1994-10-13 |
Family
ID=20375091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69009989T Expired - Lifetime DE69009989T2 (de) | 1989-02-17 | 1990-02-13 | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0458892B1 (de) |
| JP (1) | JP3007683B2 (de) |
| KR (1) | KR0139221B1 (de) |
| AT (1) | ATE107166T1 (de) |
| AU (1) | AU643431B2 (de) |
| CA (1) | CA2045618A1 (de) |
| DE (1) | DE69009989T2 (de) |
| DK (1) | DK0458892T3 (de) |
| ES (1) | ES2055421T3 (de) |
| HK (1) | HK44597A (de) |
| IE (1) | IE64622B1 (de) |
| IL (1) | IL93243A (de) |
| NZ (1) | NZ232499A (de) |
| PH (1) | PH26372A (de) |
| SE (1) | SE8900564D0 (de) |
| WO (1) | WO1990009174A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP921128B1 (en) * | 1991-10-30 | 1998-10-31 | Sandor Garaczy | Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof |
| SE9802119D0 (sv) * | 1998-06-15 | 1998-06-15 | Astra Ab | New use |
| SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
| SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE196140C1 (de) * | 1964-01-01 |
-
1989
- 1989-02-17 SE SE8900564A patent/SE8900564D0/xx unknown
-
1990
- 1990-02-01 IL IL9324390A patent/IL93243A/en not_active IP Right Cessation
- 1990-02-09 IE IE46090A patent/IE64622B1/en not_active IP Right Cessation
- 1990-02-12 PH PH40041A patent/PH26372A/en unknown
- 1990-02-13 DE DE69009989T patent/DE69009989T2/de not_active Expired - Lifetime
- 1990-02-13 ES ES90903980T patent/ES2055421T3/es not_active Expired - Lifetime
- 1990-02-13 DK DK90903980.2T patent/DK0458892T3/da active
- 1990-02-13 JP JP2503995A patent/JP3007683B2/ja not_active Expired - Lifetime
- 1990-02-13 WO PCT/SE1990/000093 patent/WO1990009174A1/en active IP Right Grant
- 1990-02-13 NZ NZ232499A patent/NZ232499A/xx unknown
- 1990-02-13 EP EP90903980A patent/EP0458892B1/de not_active Expired - Lifetime
- 1990-02-13 AT AT90903980T patent/ATE107166T1/de not_active IP Right Cessation
- 1990-02-13 CA CA002045618A patent/CA2045618A1/en not_active Withdrawn
- 1990-02-13 AU AU51679/90A patent/AU643431B2/en not_active Ceased
-
1991
- 1991-08-16 KR KR91700916A patent/KR0139221B1/ko not_active IP Right Cessation
-
1997
- 1997-04-10 HK HK44597A patent/HK44597A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU643431B2 (en) | 1993-11-18 |
| EP0458892B1 (de) | 1994-06-15 |
| ATE107166T1 (de) | 1994-07-15 |
| DE69009989D1 (de) | 1994-07-21 |
| ES2055421T3 (es) | 1994-08-16 |
| IL93243A0 (en) | 1990-11-29 |
| EP0458892A1 (de) | 1991-12-04 |
| WO1990009174A1 (en) | 1990-08-23 |
| IE900460L (en) | 1990-08-17 |
| IL93243A (en) | 1994-08-26 |
| JP3007683B2 (ja) | 2000-02-07 |
| KR920700641A (ko) | 1992-08-10 |
| NZ232499A (en) | 1992-12-23 |
| KR0139221B1 (en) | 1998-05-15 |
| AU5167990A (en) | 1990-09-05 |
| PH26372A (en) | 1992-06-01 |
| DK0458892T3 (da) | 1994-08-15 |
| CA2045618A1 (en) | 1990-08-18 |
| SE8900564D0 (sv) | 1989-02-17 |
| IE64622B1 (en) | 1995-08-23 |
| HK44597A (en) | 1997-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59310327D1 (de) | Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura | |
| DE10199020I1 (de) | Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit | |
| ATE127342T1 (de) | Verwendung von modafinil zur herstellung eines antiischämischen arzneimittels. | |
| DE122005000002I1 (de) | Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz. | |
| ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| ATE384703T1 (de) | Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen | |
| DE69407419T2 (de) | 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe | |
| DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
| DE68903840D1 (de) | Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen. | |
| DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| MX9304185A (es) | Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina. | |
| DE69021257D1 (de) | Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL. | |
| DE69009989D1 (de) | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. | |
| ATE135220T1 (de) | Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose | |
| DE3686097D1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
| EP0343671A3 (en) | Pharmaceutical composition for the treatment of skin wounds | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| DE68913779D1 (de) | D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid. | |
| IL68422A0 (en) | Hydantoin derivatives and their use in medicine | |
| EP0407788A3 (en) | Use of retinoids for the treatment and prophylaxis of immune related diseases | |
| DE3579642D1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. | |
| DE69311286D1 (de) | Verwendung von Melatonin zur Herstellung eines Arzneimittels zur Behandlung von Scleroderma und der Sarcoidosis | |
| HUT60145A (en) | Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax | |
| ATE56360T1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. | |
| PT86794A (pt) | Process for the preparation of compositions for the treatment of wood and processes of treating wood |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |